Dublin, Dec. 19, 2016 -- Research and Markets has announced the addition of the "Opioid Addiction Drugs Price Analysis and Strategies - 2016" report to their offering.
Opioid Addiction Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Opioid Addiction market.
The research answers the following questions:
- What are the key drugs marketed for Opioid Addiction and their clinical attributes? How are they positioned in the Global Opioid Addiction market?
- What are the unit prices and annual treatment cost for Opioid Addiction therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
- What are the unmet needs in the global Opioid Addiction drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Opioid Addiction?
Research Scope:
- Treatment Options - Identify key drugs marketed and prescribed for Opioid Addiction including trade name, molecule name, and company
- Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Opioid Addiction
- Market Positioning - Identify how drugs are clinically and commercially positioned in the global Opioid Addiction market
- Opioid Addiction Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
- Find out how the price advanced from 2012 and forecast to 2021
- Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
- Opioid Addiction New Drug Pricing - Identify the effective pricing strategy for a new drug launch
Key Topics Covered:
1. Treatment Options
2. Drugs Clinical Attributes
3. Drugs Market Positioning
4. Drugs Price Analysis
5. Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
7. Drugs Price Forecast
8. Market Unmet Needs
9. New Drug Pricing
For more information about this report visit http://www.researchandmarkets.com/research/cd6kww/opioid_addiction
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Addiction Disorders Drugs


Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Bank of America's $72.5M Epstein Settlement: What You Need to Know 



